Colchicine in Chronic Kidney Disease Patients

Summary

The ColchiRen study is a phase 3, controlled, prospective, randomized, double-blind, and multicenter clinical trial. Its main objective is to demonstrate the benefit of low-dose colchicine treatment in secondary prevention of cardiovascular events in patients with moderate CKD. As a secondary objective, it aims to explore the potential beneficial anti-inflammatory effect on the progression of CKD.

Timeline

Start

2025-02-12

Primary completion

2028-12-30

Completion

2028-12-30

Drugs

Indications